ID

11991

Descrizione

Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01528865 Principal Investigator: Scott D Gitlin, MD

collegamento

https://clinicaltrials.gov/show/NCT01528865

Keywords

versioni (1)
  1. 30/08/15 30/08/15 -
Caricato su

30 agosto 2015

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Lymphoma NCT01528865

Inglese

Eligibility Lymphoma NCT01528865

1 moduli  
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT01528865
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
Patients must have a histologically confirmed diagnosis of non-Hodgkin lymphoma (NHL)
Descrizione

Patients must have a histologically confirmed diagnosis of non-Hodgkin lymphoma (NHL)

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0024305
UMLS CUI [2]
C0011900
Must have HERV-K(HML2) viral load of ≥1x103 using a gag primer reverse transcriptase polymerase chain reaction (RT-PCR) assay.
Descrizione

Must have HERV-K(HML2) viral load of ≥1x103 using a gag primer reverse transcriptase polymerase chain reaction (RT-PCR) assay

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1012096
UMLS CUI [2]
C0599161
Must have bi-dimensionally measurable disease.
Descrizione

Must have bi-dimensionally measurable disease.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1513041
Patients with lymphomas that are felt to be incurable with any therapy and for whom there are no standard treatments that would be anticipated to be necessary or beneficial within the next 5 months. These patients can have received any amount of prior chemotherapy to enter this trial.
Descrizione

Patients with lymphomas that are felt to be incurable with any therapy and for whom there are no standard treatments that would be anticipated to be necessary or beneficial within the next 5 months. These patients can have received any amount of prior chemotherapy to enter this trial.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0024299
UMLS CUI [2]
C0175969
All previous therapies must have been discontinued at least 4 weeks prior to initiation of the administration of this study's drugs.
Descrizione

All previous therapies must have been discontinued at least 4 weeks prior to initiation of the administration of this study's drugs.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0677162
HIV negative by standard blood testing.
Descrizione

HIV negative by standard blood testing.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0481430
Have an expected life expectancy of at least 5 months.
Descrizione

Have an expected life expectancy of at least 5 months.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0023671
Have an Eastern Cooperative Oncology Group (ECOG) performance scale status of 0 - 2l) Must have a serum creatinine <2.0 and creatinine clearance >30 ml/min/m2. Other organ dysfunction is eligible at the discretion of the PI.
Descrizione

Have an Eastern Cooperative Oncology Group (ECOG) performance scale status of 0 - 2l) Must have a serum creatinine <2.0 and creatinine clearance >30 ml/min/m2. Other organ dysfunction is eligible at the discretion of the PI.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
UMLS CUI [2]
C0600061
UMLS CUI [3]
C0812399
Agree to use a reliable method of birth control prior to drug initiation and for the duration of their study participation.
Descrizione

Agree to use a reliable method of birth control prior to drug initiation and for the duration of their study participation.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0700589
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI-1
C0680251
a) Have received chemotherapy or radiotherapy within 4 weeks
Descrizione

chemotherapy; radiotherapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3665472
UMLS CUI [2]
C1522449
Have not recovered from the adverse effects or toxicities of lymphoma therapy most recently administered.
Descrizione

Have not recovered from the adverse effects or toxicities of lymphoma therapy most recently administered.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0879626
UMLS CUI [2]
C0087111
Currently receiving any other investigational medication or therapy.
Descrizione

Currently receiving any other investigational medication or therapy.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0013230
Patients with a second malignancy that might interfere with interpretation of the results of this study.
Descrizione

Patients with a second malignancy that might interfere with interpretation of the results of this study.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0085183
Patients with known allergic reaction to lamivudine or tenofovir disoproxil fumarate (DF).
Descrizione

Patients with known allergic reaction to lamivudine or tenofovir disoproxil fumarate (DF).

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1527304
UMLS CUI [2]
C1099776
Patients on drugs that interfere with renal function or drugs that compete with tenofovir for active binding sites (i.e. intravenous cidofovir, acyclovir, ganciclovir, and valganciclovir).
Descrizione

Patients on drugs that interfere with renal function or drugs that compete with tenofovir for active binding sites (i.e. intravenous cidofovir, acyclovir, ganciclovir, and valganciclovir).

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1547774
UMLS CUI [2]
C0232804
Uncontrolled concurrent illnesses, including, but not limited to, active/ongoing infection, symptomatic congestive heart failure, unstable angina pectoris.
Descrizione

Uncontrolled concurrent illnesses, including, but not limited to, active/ongoing infection, symptomatic congestive heart failure, unstable angina pectoris.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0205420
UMLS CUI [2]
C0012634
Women who are pregnant, become pregnant, or are breast-feeding.
Descrizione

Women who are pregnant, become pregnant, or are breast-feeding.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0549206
UMLS CUI [2]
C0006147
Standard blood tests that are positive for HIV infection
Descrizione

Standard blood tests that are positive for HIV infection

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0745002
Ritorna all'inizio della pagina

Similar models

Eligibility Lymphoma NCT01528865

1 moduli
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT01528865
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
non-Hodgkin lymphoma (NHL); Diagnosis
Item
Patients must have a histologically confirmed diagnosis of non-Hodgkin lymphoma (NHL)
boolean
C0024305 (UMLS CUI [1])
C0011900 (UMLS CUI [2])
Human endogenous retrovirus K; Reverse Transcriptase Polymerase Chain Reaction
Item
Must have HERV-K(HML2) viral load of ≥1x103 using a gag primer reverse transcriptase polymerase chain reaction (RT-PCR) assay.
boolean
C1012096 (UMLS CUI [1])
C0599161 (UMLS CUI [2])
measurable disease
Item
Must have bi-dimensionally measurable disease.
boolean
C1513041 (UMLS CUI [1])
Lymphoma ;incurable diseases
Item
Patients with lymphomas that are felt to be incurable with any therapy and for whom there are no standard treatments that would be anticipated to be necessary or beneficial within the next 5 months. These patients can have received any amount of prior chemotherapy to enter this trial.
boolean
C0024299 (UMLS CUI [1])
C0175969 (UMLS CUI [2])
Recommend therapy discontinuation
Item
All previous therapies must have been discontinued at least 4 weeks prior to initiation of the administration of this study's drugs.
boolean
C0677162 (UMLS CUI [1])
HIV negative
Item
HIV negative by standard blood testing.
boolean
C0481430 (UMLS CUI [1])
life expectancy
Item
Have an expected life expectancy of at least 5 months.
boolean
C0023671 (UMLS CUI [1])
ECOG performance status; serum creatinine; creatinine clearance
Item
Have an Eastern Cooperative Oncology Group (ECOG) performance scale status of 0 - 2l) Must have a serum creatinine <2.0 and creatinine clearance >30 ml/min/m2. Other organ dysfunction is eligible at the discretion of the PI.
boolean
C1520224 (UMLS CUI [1])
C0600061 (UMLS CUI [2])
C0812399 (UMLS CUI [3])
birth control
Item
Agree to use a reliable method of birth control prior to drug initiation and for the duration of their study participation.
boolean
C0700589 (UMLS CUI [1])
Item Group
Exclusion Criteria
C0680251 (UMLS CUI-1)
chemotherapy; radiotherapy
Item
a) Have received chemotherapy or radiotherapy within 4 weeks
boolean
C3665472 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
Adverse effects; therapy
Item
Have not recovered from the adverse effects or toxicities of lymphoma therapy most recently administered.
boolean
C0879626 (UMLS CUI [1])
C0087111 (UMLS CUI [2])
Investigational New Drugs
Item
Currently receiving any other investigational medication or therapy.
boolean
C0013230 (UMLS CUI [1])
second malignancy
Item
Patients with a second malignancy that might interfere with interpretation of the results of this study.
boolean
C0085183 (UMLS CUI [1])
allergic reaction; Tenofovir disoproxil fumarate
Item
Patients with known allergic reaction to lamivudine or tenofovir disoproxil fumarate (DF).
boolean
C1527304 (UMLS CUI [1])
C1099776 (UMLS CUI [2])
Drug interference; renal function
Item
Patients on drugs that interfere with renal function or drugs that compete with tenofovir for active binding sites (i.e. intravenous cidofovir, acyclovir, ganciclovir, and valganciclovir).
boolean
C1547774 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
concurrent; Disease
Item
Uncontrolled concurrent illnesses, including, but not limited to, active/ongoing infection, symptomatic congestive heart failure, unstable angina pectoris.
boolean
C0205420 (UMLS CUI [1])
C0012634 (UMLS CUI [2])
pregnant; Breast Feeding
Item
Women who are pregnant, become pregnant, or are breast-feeding.
boolean
C0549206 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
HIV positive
Item
Standard blood tests that are positive for HIV infection
boolean
C0745002 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial